Profil de l'entreprise

Vous venez de lire:

Health Canada Approves INFLECTRA® (biosimilar Infliximab) for Three Additional Indications: Crohn's disease, fistulising Crohn's disease and ulcerative colitis

Nouvelles fournies par

PFIZER CANADA INC.

Jun 14, 2016, 15:01 ET